New Data Published by Omada Health Demonstrates the Impact of Coupling GLP-1s and Behavior Change Programming

SAN FRANCISCO--(BUSINESS WIRE)--Omada Health, a virtual-first healthcare provider, announces its evidence-based behavior change program as one of the lifestyle support programs through EncircleRx, an Express Scripts by Evernorth solution, to help employers and health plans manage cardiodiabesity (obesity, diabetes and cardiovascular disease). The Omada program is designed to help bolster the weight loss of EncircleRx members using GLP-1 medications for weight management. With forecasted use of